Celanese (NYSE:CE - Get Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.250-0.500 for the period, compared to the consensus earnings per share estimate of 1.630. The company issued revenue guidance of -. Celanese also updated its Q2 2025 guidance to 1.250-1.500 EPS.
Celanese Stock Up 0.3 %
Shares of CE traded up $0.14 during mid-day trading on Friday, hitting $52.75. The company's stock had a trading volume of 5,328,541 shares, compared to its average volume of 2,719,022. The company's 50-day moving average is $68.25 and its 200-day moving average is $97.16. Celanese has a 52-week low of $51.24 and a 52-week high of $172.16. The firm has a market capitalization of $5.77 billion, a price-to-earnings ratio of -3.79, a PEG ratio of 1.10 and a beta of 1.17. The company has a current ratio of 1.34, a quick ratio of 0.76 and a debt-to-equity ratio of 1.98.
Celanese (NYSE:CE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The basic materials company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.20. Celanese had a negative net margin of 14.81% and a positive return on equity of 12.86%. The firm had revenue of $2.37 billion during the quarter, compared to analysts' expectations of $2.36 billion. On average, equities research analysts forecast that Celanese will post 8.79 EPS for the current fiscal year.
Celanese Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Tuesday, February 25th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Tuesday, February 25th. This represents a $0.12 annualized dividend and a dividend yield of 0.23%. Celanese's dividend payout ratio (DPR) is presently -20.10%.
Analysts Set New Price Targets
Several research firms recently commented on CE. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Celanese from $85.00 to $70.00 and set a "buy" rating for the company in a research note on Thursday. StockNews.com lowered shares of Celanese from a "hold" rating to a "sell" rating in a research note on Thursday. Jefferies Financial Group reduced their price objective on shares of Celanese from $102.00 to $82.00 in a research note on Thursday, December 5th. Piper Sandler reduced their price objective on shares of Celanese from $98.00 to $77.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. Finally, Morgan Stanley reduced their price objective on shares of Celanese from $100.00 to $80.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Five equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $83.53.
Read Our Latest Analysis on CE
Celanese Company Profile
(
Get Free Report)
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
Further Reading
Before you consider Celanese, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celanese wasn't on the list.
While Celanese currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.